Effect of Liberal and Restrictive IV Fluids on Recovery After Gallbladder Surgery
Effect of Liberal Versus Restrictive Intravenous Fluid Administration on Postoperative Homeostasis in Patients Undergoing Laparoscopic Cholecystectomy
1 other identifier
interventional
380
1 country
1
Brief Summary
The goal of this clinical trial is to learn whether giving less intravenous (IV) fluid (restrictive administration) after surgery is as effective as giving more IV fluid (liberal administration) in maintaining body stability (homeostasis) among adults undergoing laparoscopic gallbladder removal (cholecystectomy). The main questions it aims to answer are: Does restrictive IV fluid administration maintain stable blood pressure, heart rate, and urine output after laparoscopic cholecystectomy? Are there any differences in postoperative recovery or complications between restrictive and liberal fluid regimens? Researchers will compare patients receiving liberal IV fluid administration with those receiving restrictive IV fluid administration to see if both methods maintain similar postoperative homeostasis and recovery outcomes. Participants will: Be adults aged 18-60 years (ASA class I-II) undergoing elective laparoscopic cholecystectomy. Be randomly assigned to one of two groups: Group A: Liberal IV fluid administration for 6 hours after surgery. Group B: Restrictive IV fluid administration for 6 hours after surgery. Have their vital signs (pulse, blood pressure, mean arterial pressure) and urine output recorded at multiple time points after surgery (immediate, 3, 6, 12, and 24 hours).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Dec 2025
Shorter than P25 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2025
CompletedFirst Submitted
Initial submission to the registry
December 5, 2025
CompletedFirst Posted
Study publicly available on registry
March 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 28, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 28, 2026
March 23, 2026
March 1, 2026
8 months
December 5, 2025
March 17, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Mean Systolic Blood Pressure
Mean systolic blood pressure at preoperative and 3,6, 12 and 24 hours post operatively
Day 1
Secondary Outcomes (3)
Mean Pulse Rate Per Minute
Day 1
Mean Diastolic Blood Pressure
Day 1
Mean Pulse Pressure
Day 1
Study Arms (2)
Liberal Fluid Administration
ACTIVE COMPARATOR1000ml iv fluid
Restricted Fluid Administration
EXPERIMENTAL500ml iv fluid
Interventions
500ml ringer lactate perioperatively given in laparoscopic cholecystectomy patients as compared to traditional 1000ml fluid
1000ml iv fluid given perioperatively in laparoscopic cholecystectomy
Eligibility Criteria
You may qualify if:
- All patients undergoing elective cholecystectomy
- Age : 18-60 years
- All genders
- ASA class 1 and 2
You may not qualify if:
- History of previous laparotomy
- Perforated gall bladder
- Duration of surgery more than 3 hours
- More than 100ml intra operative blood loss
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
King Edward Medical University Lahore / Mayo Hospital Lahore
Lahore, Punjab Province, 54000, Pakistan
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 5, 2025
First Posted
March 23, 2026
Study Start
December 1, 2025
Primary Completion (Estimated)
July 28, 2026
Study Completion (Estimated)
July 28, 2026
Last Updated
March 23, 2026
Record last verified: 2026-03